A modified varying-stage adaptive phase II/III clinical trial design.

about

A modified varying-stage adaptive phase II/III clinical trial design.

Item

http://www.wikidata.org/entity/Q39708750

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

A modified varying-stage adaptive phase II/III clinical trial design.

@en

A modified varying-stage adaptive phase II/III clinical trial design.

@nl

type

Item

label

A modified varying-stage adaptive phase II/III clinical trial design.

@en

A modified varying-stage adaptive phase II/III clinical trial design.

@nl

prefLabel

A modified varying-stage adaptive phase II/III clinical trial design.

@en

A modified varying-stage adaptive phase II/III clinical trial design.

@nl

P1476

A modified varying-stage adaptive phase II/III clinical trial design.

@en

P2093

Marc Vandemeulebroecke

http://www.w3.org/2001/XMLSchema#string

P2860

On closed testing procedures with special reference to ordered analysis of variance

Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).

Optimizing the data combination rule for seamless phase II/III clinical trials.

Testing and estimation in flexible group sequential designs with adaptive treatment selection.

Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts.

Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer

Group sequential and adaptive designs - a review of basic concepts and points of discussion.

Adaptive designs for confirmatory clinical trials.

Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.

Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials.

P304

368-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PST.1753

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gaohong Dong

P577

2016-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27264007

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

phase III clinical trial